GR 63799X

Known as: GR-63799X, GR63799X 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2008
01219912008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
BACKGROUND AND PURPOSE Cyclooxygenase inhibitors function to reduce levels of prostaglandin E(2) (PGE(2)) and are broadly… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Nonsteroidal anti-inflammatory cyclooxygenase inhibitors that function to reduce prostaglandin E2 (PGE2) production have been… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2006
2006
The importance of arachidonic acid metabolites on the control of cell growth, particularly those derived from cyclooxygenase… (More)
Is this relevant?
2004
2004
Prostanoid EP(2) and EP(4) receptor-mediated responses are difficult to distinguish pharmacologically because of the lack of… (More)
Is this relevant?
1999
1999
1. This study investigates the effects of two agonists of the prostanoid EP3-receptor (M&B 28767 and GR 63799X) on the infarct… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
1. Eight types and subtypes of the mouse prostanoid receptor, the prostaglandin D (DP) receptor, the prostaglandin F (FP… (More)
Is this relevant?
1997
1997
Prostaglandins (PGs) exert their effects via binding to specific cell surface receptors and influencing second messenger systems… (More)
Is this relevant?
1996
1996
PGE2 is a powerful modulator of uterine contractility, but there is uncertainty as to which receptor subtypes (EP1, EP2, EP3, or… (More)
Is this relevant?
1994
1994
1. In 13 of 15 experiments, prostaglandin E2 (PGE2) and sulprostone (a prostanoid EP1/EP3-receptor agonist) contracted isolated… (More)
Is this relevant?
1991
1991
 
Is this relevant?